quin2 has been researched along with deferoxamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faux, SP; Levy, LS; Michelangeli, F | 1 |
| Green, MH; Kruszewski, M; Lowe, JE; Szumiel, I | 1 |
| de Groot, H; Dehne, N; Lautermann, J; Petrat, F; Rauen, U | 1 |
3 other study(ies) available for quin2 and deferoxamine
| Article | Year |
|---|---|
Calcium chelator Quin-2 prevents crocidolite-induced DNA strand breakage in human white blood cells.
Topics: Aminoquinolines; Antimutagenic Agents; Asbestos, Crocidolite; Aurintricarboxylic Acid; Calcium; Chelating Agents; Deferoxamine; DNA Damage; Free Radicals; Humans; Leukocytes; Oxidative Stress; Reactive Oxygen Species | 1994 |
Comparison of effects of iron and calcium chelators on the response of L5178Y sublines to X-rays and H2O2.
Topics: Aminoquinolines; Animals; Antimutagenic Agents; Calcium; Cell Survival; Chelating Agents; Deferoxamine; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electrophoresis, Agar Gel; Fura-2; Hydrogen Peroxide; Hypoxanthine Phosphoribosyltransferase; Leukemia L5178; Mice; Mutagenesis; Mutagens; Radiation Tolerance; Regression Analysis; Tumor Cells, Cultured; X-Rays | 1995 |
Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.
Topics: 2,2'-Dipyridyl; Aminoquinolines; Animals; Antineoplastic Agents; Calcium; Cell Death; Chelating Agents; Cisplatin; Cochlea; Deafness; Deferoxamine; Epithelium; Female; Fluorescent Dyes; Guinea Pigs; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Iron; Iron Chelating Agents; Kinetics; Male; Microscopy, Fluorescence; Nitroblue Tetrazolium; Organic Chemicals; Oxidation-Reduction; Superoxides | 2001 |